Abstract
T he nanotoxicology of the biomaterials and their derivatives is an important consideration before their clinical application as drug delivery nanocarriers.
Citation
Maiti S. Toxicological Concerns of Modified Biomaterials in Drug Delivery. SM J Pharmac Ther. 2016; 2(1): 1009s